| Literature DB >> 24929292 |
Ricardo Augusto Massarico Serafim1, José Eduardo Gonçalves2, Felipe Pereira de Souza3, Ana Paula de Melo Loureiro3, Silvia Storpirtis2, Renata Krogh4, Adriano Defini Andricopulo4, Luiz Carlos Dias5, Elizabeth Igne Ferreira6.
Abstract
Hybrid bioisoster derivatives from N-acylhydrazones and furoxan groups were designed with the objective of obtaining at least a dual mechanism of action: cruzain inhibition and nitric oxide (NO) releasing activity. Fifteen designed compounds were synthesized varying the substitution in N-acylhydrazone and in furoxan group as well. They had its anti-Trypanosoma cruzi activity in amastigotes forms, NO releasing potential and inhibitory cruzain activity evaluated. The two most active compounds (6, 14) both in the parasite amastigotes and in the enzyme contain the nitro group in para position of the aromatic ring. The permeability screening in Caco-2 cell and cytotoxicity assay in human cells were performed for those most active compounds and both showed to be less cytotoxic than the reference drug, benznidazole. Compound 6 was the most promising, since besides activity it showed good permeability and selectivity index, higher than the reference drug. Thereby the compound 6 was considered as a possible candidate for additional studies.Entities:
Keywords: Anti-Trypanosoma cruzi compounds; Bioisosters; Furoxan derivatives; Molecular hybrids; N-acylhydrazone derivatives; Nitric oxide donor groups
Mesh:
Substances:
Year: 2014 PMID: 24929292 DOI: 10.1016/j.ejmech.2014.05.077
Source DB: PubMed Journal: Eur J Med Chem ISSN: 0223-5234 Impact factor: 6.514